ロード中...
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve compr...
保存先:
| 出版年: | BioDrugs |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972870/ https://ncbi.nlm.nih.gov/pubmed/27422671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-016-0185-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|